Marlies Laros

Marlies Laros is an Analyst at Aglaia BioMedical Ventures, a specialized venture capital firm dedicated to funding early-stage life sciences and health startups. Before joining her current firm, she worked as a Senior Life Sciences professional at Middenduin Life Sciences, a role she held as of 2012. Throughout her career in the biomedical investment sector, she has evaluated numerous biotechnology opportunities and participated as a co-investor in seed-stage pharmaceutical transactions. Her professional network and collaborative deal-making history include working alongside notable industry figures such as Laurens van der Flier, Karl Rothweiler, and Mark Krul. She holds a Master of Science degree, which provides the technical foundation required to assess complex medical technologies and therapeutic platforms. Laros currently focuses her investment efforts on advancing seed-stage life sciences ventures and supporting the commercialization of novel biomedical innovations.